Key result
Genetic evidence supports a causal role of elevated plasma triglycerides in the development of coronary heart disease.
Why the study?
Do genetic variants affecting plasma triglycerides have a causal role in coronary heart disease?
Population
More than 72,000 patients with coronary artery disease and 120,000 controls
Design
Editorial
Authors
Loading...
This editorial highlights genetic evidence supporting a causal relationship between plasma triglycerides and coronary heart disease.
Do genetic variants affecting plasma triglycerides have a causal role in coronary heart disease?
This editorial highlights genetic evidence supporting a causal relationship between plasma triglycerides and coronary heart disease.
Sander Kersten (2016) conducted an editorial in Coronary heart disease (n=192,000). Plasma triglycerides (genetic variants) was evaluated on Coronary heart disease. Genetic evidence supports a causal role of elevated plasma triglycerides in the development of coronary heart disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: